Modified Deauville Score including Personalized Residual TMTV improves identification of poor outcomes patients in First Line FL patients: a Bidifly-Lysa Study (EANM 2026) - Sep 29, 2026 - Abstract #OP-871; Pres time: Oct 21, 2026; 09:45 AM - 11:15 AM; Location: Hall C; "Materials and We retrospectively collected 450 FL patients from 3 Lysa first line clinical trials (EPI-RCHOP=51, GALEN=74, RELEVANCE=325)... In this large cohort of first line FL patients, residual TMTV at end of treatment in combination with Deauville score yields better stratification of patient prognosis, by reclassifying low residual tumor volume uptake (including DS5) as responding patients. This modified Deauville score may reduce the need for re-biopsy rate and may tailor novel risk adapted treatment protocols."
Clinical • Follicular Lymphoma • Hematological Malignancies • Lymphoma
|
|
Y. Al Tabaa 1; S. Malmon 2; T. Reichert 3; R. Metz 4; P. Viau 5; L. Vercellino 6; N. Deleval 7; D. Bessac 8; A. Cottereau 9; C. Antoine 10; G. Henique 11; I. Buvat 12; G. Cartron 13; C. Sarkozy 14; S. Kanoun 2
|